Pentaerythritol tetranitrate improves angiotensin II-induced vascular dysfunction via induction of heme oxygenase-1

Hypertension

Volumn 55, Issue 4, 2010, Pages 897-904

  Schuhmacher, Swenja ^a   Wenzel, Philip ^a   Schulz, Eberhard ^a   Oelze, Matthias ^a   Mang, Christian ^a   Kamuf, Jens ^a   Gori, Tommaso ^a   Jansen, Thomas ^a   Knorr, Maike ^a   Karbach, Susanne ^a   Hortmann, Marcus ^a   Mäthner, Falk ^a   Bhatnagar, Aruni ^b   Förstermann, Ulrich ^a   Li, Huige ^a   Münzel, Thomas ^a   Daiber, Andreas ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b University of Louisville School of Medicine   (United States)

Author keywords

Angiotensin II; Endothelial dysfunction; Isosorbide 5 mononitrate; Pentaerythritol tetranitrate; SHR; Vascular oxidative stress

Indexed keywords

ANGIOTENSIN II; DIHYDROFOLATE REDUCTASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; HEME OXYGENASE 1; HEMIN; HYDROETHIDINE; ISOSORBIDE 5 NITRATE; LUCIGENIN; PENTAERYTHRITYL TETRANITRATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; ENZYME INDUCTION; HYPERTENSION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE CONTRACTION; STAINING; ANALYSIS OF VARIANCE; ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM; MITOCHONDRION; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANIMALS; BLOTTING, WESTERN; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE; HEME OXYGENASE-1; HEMIN; MITOCHONDRIA; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PENTAERYTHRITOL TETRANITRATE; RATS; RATS, INBRED SHR; REACTIVE OXYGEN SPECIES; VASODILATOR AGENTS;

EID: 77950508168     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.149542     Document Type: Article

References (35)

1. Hamilton C. Nitric oxide, oxidative stress and hypertension: a complex equation. J Hypertens. 2002;20:1055-1056.
2. Touyz RM. Reactive oxygen species in vascular biology: role in arterial hypertension. Expert Rev Cardiovasc Ther. 2003;1:91-106.
3. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin ii-mediated hypertension in the rat increases vascular superoxide production via membrane nadh/nadph oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
4. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL, Tsilimingas N, Walter U, Forstermann U, Meinertz T, Griendling K, Munzel T. Effects of angio-tensin ii infusion on the expression and function of nad(p)h oxidase and components of nitric oxide/cgmp signaling. Circ Res. 2002;90:E58-E65.
5. Doughan AK, Harrison DG, Dikalov SI. Molecular mechanisms of an-giotensin ii-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ Res. 2008; 102:488-496.
6. Dikalova A, Clempus R, Lassegue B, Cheng G, McCoy J, Dikalov S, San Martin A, Lyle A, Weber DS, Weiss D, Taylor WR, Schmidt HH, Owens GK, Lambeth JD, Griendling KK. Nox1 overexpression potentiates an-giotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice. Circulation. 2005;112:2668-2676.
7. Matsuno K, Yamada H, Iwata K, Jin D, Katsuyama M, Matsuki M, Takai S, Yamanishi K, Miyazaki M, Matsubara H, Yabe-Nishimura C. Nox1 is involved in angiotensin II-mediated hypertension: a study in nox1-deficient mice. Circulation. 2005;112:2677-2685.
8. Schulz E, Jansen T, Wenzel P, Daiber A, Munzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal. 2008;10:1115-1126.
9. Wenzel P, Daiber A, Oelze M, Brandt M, Closs E, Xu J, Thum T, Bauersachs J, Ertl G, Zou MH, Forstermann U, Munzel T. Mechanisms underlying recoupling of enos by hmg-coa reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. Atherosclerosis. 2008; 198:65-76.
10. Wenzel P, Schulz E, Oelze M, Muller J, Schuhmacher S, Alhamdani MS, Debrezion J, Hortmann M, Reifenberg K, Fleming I, Munzel T, Daiber A. At1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects enos in diabetic rats. Free Radic Biol Med. 2008;45: 619-626.
11. Wenzel P, Mollnau H, Oelze M, Schulz E, Wickramanayake JM, Muller J, Schuhmacher S, Hortmann M, Baldus S, Gori T, Brandes RP, Munzel T, Daiber A. First evidence for a crosstalk between mitochondrial and NADPH oxidase-derived reactive oxygen species in nitroglycerin-triggered vascular dysfunction. Antioxid Redox Signal. 2008;10: 1435-1447.
12. Wenzel P, Hink U, Oelze M, Schuppan S, Schaeuble K, Schildknecht S, Ho KK, Weiner H, Bachschmid M, Munzel T, Daiber A. Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydro-genase (ALDH-2) activity: implications for mitochondrial oxidative stress and nitrate tolerance. J Biol Chem. 2007;282:792-799.
13. Thomas GR, DiFabio JM, Gori T, Parker JD. Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanism. J Am Coll Cardiol. 2007;49:1289-1295.
14. Daiber A, Oelze M, Coldewey M, Bachschmid M, Wenzel P, Sydow K, Wendt M, Kleschyov AL, Stalleicken D, Ullrich V, Mulsch A, Munzel T. Oxidative stress and mitochondrial aldehyde dehydrogenase activity: a comparison of pentaerythritol tetranitrate with other organic nitrates. Mol Pharmacol. 2004;66:1372-1382.
15. Nakamura Y, Moss AJ, Brown MW, Kinoshita M, Kawai C. Long-term nitrate use may be deleterious in ischemic heart disease: a study using the databases from two large-scale postinfarction studies-multicenter myo-cardial ischemia research group. Am Heart J. 1999;138:577-585.
16. Jurt U, Gori T, Ravandi A, Babaei S, Zeman P, Parker JD. Differential effects of pentaerythritol tetranitrate and nitroglycerin on the development of tolerance and evidence of lipid peroxidation: a human in vivo study. J Am Coll Cardiol. 2001;38:854-859.
17. Gori T, Al-Hesayen A, Jolliffe C, Parker JD. Comparison of the effects of pentaerythritol tetranitrate and nitroglycerin on endothelium-dependent vasorelaxation in male volunteers. Am J Cardiol. 2003;91:1392-1394.
18. Oelze M, Daiber A, Brandes RP, Hortmann M, Wenzel P, Hink U, Schulz E, Mollnau H, von Sandersleben A, Kleschyov AL, Mulsch A, Li H, Forstermann U, Munzel T. Nebivolol inhibits superoxide formation by nadph oxidase and endothelial dysfunction in angiotensin II-treated rats. Hypertension. 2006;48:677-684.
19. Mollnau H, Wenzel P, Oelze M, Treiber N, Pautz A, Schulz E, Schuh-macher S, Reifenberg K, Stalleicken D, Scharffetter-Kochanek K, Kleinert H, Munzel T, Daiber A. Mitochondrial oxidative stress and nitrate tolerance: comparison of nitroglycerin and pentaerithrityl tetranitrate in Mn-SOD+/\mice. BMC Cardiovasc Disord. 2006;6:44.
20. Oelze M, Warnholtz A, Faulhaber J, Wenzel P, Kleschyov AL, Coldewey M, Hink U, Pongs O, Fleming I, Wassmann S, Meinertz T, Ehmke H, Daiber A, Munzel T. NADPH oxidase accounts for enhanced superoxide production and impaired endothelium-dependent smooth muscle relaxation in bk/31\/\mice. Arterioscler Thromb Vasc Biol. 2006;26: 1753-1759.
21. Wenzel P, Oelze M, Coldewey M, Hortmann M, Seeling A, Hink U, Mollnau H, Stalleicken D, Weiner H, Lehmann J, Li H, Forstermann U, Munzel T, Daiber A. Heme oxygenase-1: a novel key player in the development of tolerance in response to organic nitrates. Arterioscler Thromb Vasc Biol. 2007;27:1729-1735.
22. Ishizaka N, Griendling KK. Heme oxygenase-1 is regulated by angiotensin II in rat vascular smooth muscle cells. Hypertension. 1997;29: 790-795.
23. Oelze M, Mollnau H, Hoffmann N, Warnholtz A, Bodenschatz M, Smo-lenski A, Walter U, Skatchkov M, Meinertz T, Munzel T. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cgmp signaling and endothelial dysfunction. Circ Res. 2000;87:999-1005.
24. Mollnau H, Oelze M, August M, Wendt M, Daiber A, Schulz E, Baldus S, Kleschyov AL, Materne A, Wenzel P, Hink U, Nickenig G, Fleming I, Munzel T. Mechanisms of increased vascular superoxide production in an experimental model of idiopathic dilated cardiomyopathy. Arterioscler Thromb Vasc Biol. 2005;25:2554-2559.
25. Hink U, Li H, Mollnau H, Oelze M, Matheis E, Hartmann M, Skatchkov M, Thaiss F, Stahl RA, Warnholtz A, Meinertz T, Griendling K, Harrison DG, Forstermann U, Munzel T. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 2001;88:E14-E22.
26. Hink U, Oelze M, Kolb P, Bachschmid M, Zou MH, Daiber A, Mollnau H, August M, Baldus S, Tsilimingas N, Walter U, Ullrich V, Munzel T. Role for peroxynitrite in the inhibition of prostacyclin synthase in nitrate tolerance. J Am Coll Cardiol. 2003;42:1826-1834.
27. Kuzkaya N, Weissmann N, Harrison DG, Dikalov S. Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J Biol Chem. 2003;278: 22546-22554.
28. Warnholtz A, Mollnau H, Heitzer T, Kontush A, Moller-Bertram T, Lavall D, Giaid A, Beisiegel U, Marklund SL, Walter U, Meinertz T, Munzel T. Adverse effects of nitroglycerin treatment on endothelial function, vascular nitrotyrosine levels and cgmp-dependent protein kinase activity in hyperlipidemic watanabe rabbits. J Am Coll Cardiol. 2002;40: 1356-1363.
29. Chalupsky K, Cai H. Endothelial dihydrofolate reductase: Critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase. Proc Natl Acad Sci USA. 2005;102: 9056-9061.
30. Drummond GR, Cai H, Davis ME, Ramasamy S, Harrison DG. Tran-scriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res. 2000;86:347-354.
31. Takahashi T, Morita K, Akagi R, Sassa S. Heme oxygenase-1: a novel therapeutic target in oxidative tissue injuries. Curr Med Chem. 2004;11: 1545-1561.
32. Mullenheim J, Muller S, Laber U, Thamer V, Meyer W, Bassenge E, Fink B, Kojda G. The effect of high-dose pentaerythritol tetranitrate on the development of nitrate tolerance in rabbits. Naunyn Schmiedebergs Arch Pharmacol. 2001;364:269-275.
33. Hacker A, Muller S, Meyer W, Kojda G. The nitric oxide donor pentae-rythritol tetranitrate can preserve endothelial function in established atherosclerosis. Br J Pharmacol. 2001;132:1707-1714.
34. Muller S, Konig I, Meyer W, Kojda G. Inhibition of vascular oxidative stress in hypercholesterolemia by eccentric isosorbide mononitrate. J Am Coll Cardiol. 2004;44:624-631.
35. Muller S, Laber U, Mullenheim J, Meyer W, Kojda G. Preserved endo-thelial function after long-term eccentric isosorbide mononitrate despite moderate nitrate tolerance. J Am Coll Cardiol. 2003;41:1994-2000.